Gaudium IVF IPO Allotment Today: How to check status and when shares will list

Gaudium IVF IPO Allotment: Investors are eyeing the allotment of India's first women health clinic issue, Gaudium IVF IPO, which is likely to be finalised on Wednesday, February 25, 2026. The allotment will be followed by the crediting of shares to the demat accounts of successful bidders and the initiation of refunds to the unsuccessful ones.
Gaudium IVF IPO Allotment Today: How to check status and when shares will list
Gaudium IVF IPO was a book-built issue worth Rs 165 crore |Image source: Freepik|

Gaudium IVF IPO: Investors are eyeing the allotment of India's first women's health clinic issue, Gaudium IVF IPO, which is likely to be finalised on Wednesday, February 25, 2026. The allotment will be followed by the crediting of shares to the demat accounts of successful bidders and the initiation of refunds to the unsuccessful ones.

The fertility services provider concluded its Rs 165 crore book-built IPO with a 7.27 times overall subscription, according to provisional exchange data.

How to check Gaudium IVF IPO allotment status online?

Add Zee Business as a Preferred Source

Investors who have applied for the IPO can check their allotment status online on the websites of BSE and NSE, or the issue registrar, Bigshare Services. Here's how you can view your allotment status step-by-step through the direct links:

Check Gaudium IVF IPO allotment status on NSE

2) Select 'Equity and SME IPO bid details'

3) Choose 'GAUDIUMIVF' from the dropdown list

4) Enter your PAN and application number

5) Click submit

Check Gaudium IVF IPO allotment status on BSE

2) Select 'Equity' under issue type

3) Choose 'Gaudium IVF and Women Health Ltd'

4) Enter your application number or PAN

5) Click search to view your allotment status

Check Gaudium IVF IPO allotment status on Bigshare Services

1) Visit the MUFG Intime India website:- https://ipo.bigshareonline.com/ipo_status.html

2) Choose among the three servers

2) Select 'Gaudium IVF and Women Health' from the dropdown menu

3) Enter your PAN, application number, or beneficiary ID

4) Click search to check your status

Gaudium IVF IPO subscription highlights

Overall, the IPO received bids for 10.63 crore shares against an offer of 1.46 crore shares, resulting in a 7.27 times the overall subscription.

  • Qualified Institutional Buyers (QIBs) booked 1.62 times, with 67.85 lakh shares bid against 41.77 lakh shares.
  • Non-Institutional Investors (NIIs) subscribed 14.05 times, with 4.40 crore shares bid against 31.32 lakh reserved.
  • Retail Individual Investors (RIIs) booked 7.60 times with 5.55 crore shares bid against 73.10 lakh shares allotted.

Gaudium IVF and Women Health IPO details

Gaudium IVF IPO was a book-built issue worth Rs 165 crore, consisting of a fresh issue of 1.14 crore equity shares (Rs 90 crore) and an offer for sale (OFS) of 0.95 crore shares (Rs 75 crore).

According to the company's RHP, Sarthi Capital Advisors Pvt Ltd is the book-running lead manager to the issue, while Bigshare Services Pvt Ltd has been appointed as the registrar.

Price band: The IPO was priced at Rs 75 to Rs 79 per share, giving the company a market valuation of around Rs 575 crore at the upper end.

Subscription date: The IPO opened for subscription on February 20, 2026, and will close on February 24, 2026.

Listing date: The IPO shares are expected to list on the stock exchanges with a tentative listing date fixed as February 27, 2026.

Lot size: Investors could apply for a lot size of 189 shares, requiring a minimum investment of Rs 14,931 for retail applicants at the upper price band.

Gaudium IVF and Women Health Limited company profile

Incorporated in March 2015, Gaudium IVF and Women Health Limited provides In Vitro Fertilisation (IVF) treatments across India and has expanded into multiple states through a hub-and-spoke model.

The company operates over 30 locations, including seven hubs and 28 spokes, and has entered into a strategic alliance with Infertility Experts (Spokes) to increase awareness about Assisted Reproductive Technology (ART) and IVF treatments.

Its specialised fertility services include IVF, Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction.